Thailand Emerges as a Leader in Genomic Medicine in Asia, Opens Genetic Database for International-Level Research
Thailand has announced a significant milestone in advancing its public health sector by emerging as a leader in genomic medicine in the Asian region. Recently, a large-scale genetic database was launched, allowing medical professionals and researchers nationwide to access this vital information.
The launch of this database is conducted through a system known as a 'Trusted Research Environment' (TRE), which adheres to international security standards to protect the personal data of project participants and build confidence among all stakeholders.
The primary goal of opening this database is to support Thai researchers in utilizing genetic data to further develop more precise treatments, particularly for genetic-related diseases, cancer, and rare diseases, which will help make future patient care more effective and targeted.
This advancement not only helps elevate the standard of medical care in Thailand to a global level but also creates opportunities for Thai researchers to innovate new medical solutions that will benefit the health of the Thai people in the long term.
The development of genetic data infrastructure is considered a crucial step for Thailand as it enters the era of modern medicine, which focuses on prevention and personalized treatment. This will serve as a vital foundation for developing a stronger and more sustainable national public health system.